2nd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$435,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

Unlock Student Loan Auction Rate Securities (SLARS)

LobbyistCovered position, as disclosed
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Financial Institutions/Investments/Securities FIN

Unlock Student Loan Auction Rate Securities (SLARS)

LobbyistCovered position, as disclosed
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Obesity awareness as a medical condition Metastatic breast cancer awareness

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

H.R. 2415, The Treat and Reduce Obesity Act of 2013 S. 1184, The Treat and Reduce Obesity Act of 2013 H.R.1416, The Cancer Patient Protection Act of 2013

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1416 (113th), S. 1184 (113th), H.R. 2415 (113th)

Pharmacy PHA

FDA/DEA controlled substances scheduling processes and delays H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013, "Track and Trace" legislation S. 957, The Drug Supply Chain Security Act, "Track and Trace" legislation

LobbyistCovered position, as disclosed
PETER NORMAN —
KATIE OPPENHEIM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1919 (113th), S. 957 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.